BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26509668)

  • 1. Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population.
    Salo PP; Vaara S; Kettunen J; Pirinen M; Sarin AP; Huikuri H; Karhunen PJ; Eskola M; Nikus K; Lokki ML; Ripatti S; Havulinna AS; Salomaa V; Palotie A; Nieminen MS; Sinisalo J; Perola M
    PLoS One; 2015; 10(10):e0140576. PubMed ID: 26509668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
    Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease.
    Ellis KL; Frampton CM; Pilbrow AP; Troughton RW; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Thomson J; Yandle TG; Richards AM; Cameron VA
    Circ Cardiovasc Genet; 2011 Dec; 4(6):636-46. PubMed ID: 21984477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels.
    Gigante B; Leander K; Vikström M; Ye S; de Faire U
    BMC Cardiovasc Disord; 2012 Oct; 12():90. PubMed ID: 23067240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with no significant lesions in coronary arteries and ST-segment elevation myocardial infarction have worse outcome than patients with non-ST-segment elevation myocardial infarction: analysis from PL-ACS Registry.
    Frycz-Kurek AM; Gierlotka M; Gąsior M; Wilczek K; Lekston A; Kalarus Z; Poloński L
    Kardiol Pol; 2010 Nov; 68(11):1211-7. PubMed ID: 21108194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.
    Chan MY; Sun JL; Newby LK; Shaw LK; Lin M; Peterson ED; Califf RM; Kong DF; Roe MT
    Circulation; 2009 Jun; 119(24):3110-7. PubMed ID: 19506116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR.
    Anderson ML; Peterson ED; Peng SA; Wang TY; Ohman EM; Bhatt DL; Saucedo JF; Roe MT
    Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):708-15. PubMed ID: 24221834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Abbott JD; Ahmed HN; Vlachos HA; Selzer F; Williams DO
    Am J Cardiol; 2007 Jul; 100(2):190-5. PubMed ID: 17631068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
    Shen L; Shah BR; Nam A; Holmes D; Alexander KP; Bhatt DL; Ho PM; Peterson ED; He B; Roe MT
    Am Heart J; 2014 Jun; 167(6):840-5. PubMed ID: 24890533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
    Bauer T; Gitt AK; Hochadel M; Möllmann H; Nef H; Weidinger F; Zahn R; Hamm CW; Marco J; Zeymer U
    Int J Cardiol; 2013 Oct; 168(6):5239-42. PubMed ID: 23998547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
    Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
    Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.
    Park HW; Yoon CH; Kang SH; Choi DJ; Kim HS; Cho MC; Kim YJ; Chae SC; Yoon JH; Gwon HC; Ahn YK; Jeong MH;
    Int J Cardiol; 2013 Nov; 169(4):254-61. PubMed ID: 24071385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry.
    Scheffold T; Kullmann S; Huge A; Binner P; Ochs HR; Schöls W; Thale J; Motz W; Hegge FJ; Stellbrink C; Dorsel T; Gülker H; Heuer H; Dinh W; Stoll M; Haltern G;
    BMC Cardiovasc Disord; 2011 Mar; 11():9. PubMed ID: 21385355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs.
    Grimaldi-Bensouda L; Rossignol M; Danchin N; Steg PG; Bessede G; Ovize M; Cottin Y; Autret-Leca E; Benichou J; Abenhaim L;
    Heart; 2011 Nov; 97(22):1834-40. PubMed ID: 21880652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction.
    Paakkanen R; Lokki ML; Seppänen M; Tierala I; Nieminen MS; Sinisalo J
    Atherosclerosis; 2012 Apr; 221(2):461-6. PubMed ID: 22310063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease.
    Johnston N; Jönelid B; Christersson C; Kero T; Renlund H; Schenck-Gustafsson K; Lagerqvist B
    Am J Cardiol; 2015 Jun; 115(12):1661-6. PubMed ID: 25900352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between 1p13.3 genomic markers and coronary artery disease: a meta-analysis involving patients and controls.
    Guo J; Luo YX; Tao LX; Guo XH
    Genet Mol Res; 2015 Aug; 14(3):9092-102. PubMed ID: 26345841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction.
    Shen GQ; Li L; Girelli D; Seidelmann SB; Rao S; Fan C; Park JE; Xi Q; Li J; Hu Y; Olivieri O; Marchant K; Barnard J; Corrocher R; Elston R; Cassano J; Henderson S; Hazen SL; Plow EF; Topol EJ; Wang QK
    Am J Hum Genet; 2007 Oct; 81(4):780-91. PubMed ID: 17847002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention.
    Song YB; Hahn JY; Kim JH; Lee SY; Choi SH; Choi JH; Choi SH; Lee SH; Yoon J; Kim YJ; Jeong MH; Gwon HC;
    Am J Cardiol; 2010 Nov; 106(10):1397-403. PubMed ID: 21059427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.